DoD Lung Cancer Concept Award | Apply Online

DoD Lung Cancer Concept Award (W81XWH-14-LCRP-CA) FAQs

1) What is the DoD Lung Cancer Concept Award?

The DoD Lung Cancer Concept Award (Funding Opportunity Number W81XWH-14-LCRP-CA) is a funding mechanism under the Department of Defense Lung Cancer Research Program designed to spark genuinely new directions in lung cancer research by supporting highly innovative ideas or untested theories.

2) What is the main purpose of this award?

The core purpose is to fund early-stage, high-risk lung cancer research concepts that could have high payoff. The program is aimed at work that could open entirely new avenues of investigation, rather than extending or refining an existing, well-developed research project.

3) What type of research approach is this opportunity trying to encourage?

This opportunity is meant for bold, innovative concepts with strong scientific logic, including projects that follow up on unexpected findings or serendipitous observations, as long as the underlying rationale is sound and the idea addresses an important lung cancer problem.

4) Is this award meant for incremental or well-established projects?

No. The program framing emphasizes genuinely new directions and discourages projects that primarily extend, refine, or further develop a well-established line of work.

5) Are preliminary data required?

No. A defining feature of this Concept Award is that it discourages the inclusion of preliminary data. This is intentional and intended to reduce barriers for high-risk, early-stage concepts that may not yet have supporting datasets.

6) If preliminary data are discouraged, what must applicants provide instead?

Applicants are still expected to provide clear logical reasoning, a sound scientific rationale, and a convincing explanation of how the concept would enhance current knowledge about lung cancer or create a fundamentally new research pathway.

7) What is the expected outcome if the project is successful?

The expectation is that a successful project will generate enough early evidence or feasibility signals to support future, more fully developed applications.

8) How important is military relevance for this award?

Military relevance is a strong emphasis of the opportunity. The Lung Cancer Research Program seeks projects that matter to the health care needs of military service members, Veterans, their families, and other beneficiaries of the Military Health System.

9) How is military relevance evaluated?

Military relevance is considered during programmatic review when determining how well an application aligns with the mission of the Defense Health Program and the specific priorities of the fiscal year program.

10) What are examples of ways to demonstrate military relevance?

The opportunity encourages applicants to demonstrate military relevance in concrete ways, such as:

• Using military or Veteran populations or datasets
• Collaborating with Department of Defense (DoD) or Department of Veterans Affairs (VA) investigators
• Including military consultants or specialty leaders connected to the Surgeons General
• Clearly explaining how the lung cancer issue being studied directly affects service members, Veterans, or related patient populations

11) Which agency is offering this funding opportunity?

This is a discretionary funding opportunity offered by the Department of the Army through USAMRAA (U.S. Army Medical Research Acquisition Activity).

12) What types of funding instruments are used?

The opportunity uses grant and cooperative agreement instruments.

13) How is this opportunity categorized?

It is categorized under science and technology research and development.

14) How many awards were anticipated, and what was the estimated total funding?

The solicitation anticipated making about 12 awards, with an estimated total funding amount of $1.92 million.

15) Is cost sharing or matching required?

No. The opportunity did not require cost sharing or matching funds.

16) Who is eligible to apply?

Eligibility was described as unrestricted, meaning it was broadly open to many entity types, subject to any additional eligibility clarifications in the full announcement.

17) What are the key dates for this opportunity?

The posting date was May 20, 2014. The application deadline was August 12, 2014. The opportunity was later archived on September 11, 2014.

18) What does it mean that the opportunity is archived?

The listing notes that it was archived on September 11, 2014, indicating it is no longer an active posting under that listing.

19) Where can applicants get help accessing the full announcement?

Applicants needing help accessing the full announcement were directed to the CDMRP eBRAP Help Desk at 301-682-5507 or help@eBRAP.org.

20) What kind of lung cancer problems is the award trying to address?

The award is intended to support untested theories or innovative ideas that tackle an important lung cancer problem, with an emphasis on concepts that could change or expand the field by creating new investigative pathways.